Future Sight with Capgemini Invent

This week we're looking to the future implications of the COVID-19 vaccines that are currently being brought to market. We're going to dig into the supply chains, societal issues, and how the processes created will fundamentally change how we approach life sciences going forward.

Show Notes

A big thank you to Kate Broderick, Senior Vice President R&D at Inovio Pharmaceuticals Inc and to Eliza Silvester, Principal at Life Sciences, Capgemini Invent. We would also like to thank Etienne Grass, Executive Vice President - Head of Citizen Services @ Capgemini Invent for his support.

Read more about this topic in our latest POV, Covid-19 vaccines are coming. Are we ready? here: https://www.capgemini.com/resources/covid-19-vaccines-are-coming-are-we-ready/ 

This episode was hosted by Ollie Judge and produced by Theresa Ignatius, Emmanuel Lochon & Oliver Jones. This series was created for Capgemini Invent by Adrift Entertainment.

This podcast is brought to you by Capgemini Invent. You can find out more about them at https://www.capgemini.com/service/invent/ and follow them on Twitter https://twitter.com/CapgeminiInvent.

What is Future Sight with Capgemini Invent?

Every day business and technology move forward at a rapid rate, it becomes increasingly important to explore new ways to adapt and grow for the future. Being up to date on the latest technology is important but not enough for you to get the future you want; more important is understanding and anticipating what’s coming next.

Future Sight is your guide to that journey. We bring industry-leading experts together to unpack a new way of thinking around the challenges we're facing today that will affect tomorrow. We dig into the issues that they and their industries are facing and break down the need to know actionable approaches and strategic insight that will help plot what's next for you and your business.